Forward-thinking, innovative startups can play a pivotal function in developing new tips and technologies to greatly help stimulate developments in medicine and technology, said American University of Cardiology CEO Shal Jacobovitz. We are proud to partner with 1776 and Challenge Cup because these new businesses have the potential to greatly help us fulfill our mission to transform cardiovascular care and improve wellness. As a key part of 1776's incubation model, connecting startups with high-level mentors and corporate companions is just as important as connecting startups to capital and venture funds. Association partners like the ACC bring in startups to potential customers, industry and investors leaders that may take their company to the next level. Related StoriesNew Haven Pharmaceuticals' DURLAZA medication delivers sustained antiplatelet control for full 24 hoursDrinking one 16-ounce energy drink may increase risk of cardiovascular occasions in young adultsPurple Switch cellular app helps HMC accomplish overall goal of improving individual safety, qualityAs a Problem Cup partner, the ACC provides this calendar year's regional winners with an unparalleled possibility to learn about health care and pitch their businesses: an all-expense paid visit to participate in its 64th Annual Scientific Session in San Diego.‘By using Western scientific rigor to validate a historical Eastern therapy, we feel we’ve integrated Chinese and Western medication and provided a beneficial guideline for treating an illness that affects thousands in the U.S.’ Related StoriesResearch finding may lead to brand-new treatment to market brain repair, useful recovery after strokeHeart disease turns into the main killer of women in NorwayWyss Institute, UMass synergy to develop drug-device mixture for treating blood clots in stroke patientsLonghurst and his UCI co-workers Dr. Peng Li and Stephanie Tjen-A-Looi conducted exams on 65 hypertensive patients who weren’t receiving any hypertension medication.